ANTITUMOR MECHANISMS OF 3'-ETHYNYLURIDINE AND 3'-ETHYNYLCYTIDINE AS RNA-SYNTHESIS INHIBITORS - DEVELOPMENT AND CHARACTERIZATION OF 3'-ETHYNYLURIDINE-RESISTANT CELLS

Citation
S. Tabata et al., ANTITUMOR MECHANISMS OF 3'-ETHYNYLURIDINE AND 3'-ETHYNYLCYTIDINE AS RNA-SYNTHESIS INHIBITORS - DEVELOPMENT AND CHARACTERIZATION OF 3'-ETHYNYLURIDINE-RESISTANT CELLS, Cancer letters, 116(2), 1997, pp. 225-231
Citations number
21
Categorie Soggetti
Oncology
Journal title
ISSN journal
03043835
Volume
116
Issue
2
Year of publication
1997
Pages
225 - 231
Database
ISI
SICI code
0304-3835(1997)116:2<225:AMO3A3>2.0.ZU;2-1
Abstract
To discover the mechanisms of anti-tumor action of 3'-ethynyluridine ( EUrd) and 3'-ethynylcytidine (ECyd), we established an EUrd-resistant variant from human fibrosarcoma HT-1080 cells. The cells were cross-re sistant to ECyd. Uridine/cytidine kinase activity diminished in the re sistant cells. The incorporation of EUrd and ECyd into the RNA fractio n in the resistant cells was less than that of the parental cells. EUr d-triphosphate inhibited RNA synthesis by human RNA polymerase II. The results led us to conclude that EUrd and ECyd are phosphorylated by u ridine/cytidine kinase to 5'-triphosphates, and that their triphosphat es might inhibit RNA polymerase. (C) 1997 Elsevier Science Ireland Ltd .